Former Sky News anchor Ahron Young interview with Su Zhang, CEO of Star Combo Pharma (ASX:S66) on Ticker live.
(Ahron Young and Su Zhang)
Star Combo Pharma recently announced their expansion into the global milk market and a land acquisition to develop a modern R&D and test laboratory.
This is an important milestone in the company’s growth strategy, S66 aim to be Australia’s leading manufacturer in the health supplement sector. These expansion plans are part of their commitment to address the growing demand for Australian made premium vitamins and dietary supplements.
Su Zhang, CEO of Star Combo Pharma provided commentary on the significance of these developments and in addition provided further insight on the following topics:
· The growing demand for vitamins and supplements during COVID-19
· Despite trade tensions, S66 still believes there is a strong opportunity for Australian milk powder brands
· Healthcare manufacturing is experiencing a renaissance and Australian manufacturing has been identified as a potential source of growth post-COVID
· S66 is committed to keeping manufacturing onshore
News quote from:Ticker TV
Tel: +61 2 9756 6555
Add: 171 - 177 Woodpark Rd, Smithfield NSW 2164